{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:49:34Z","timestamp":1793317774531,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R35HL155657"],"award-info":[{"award-number":["1R35HL155657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rpthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research and Practice in Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.rpth.2023.100123","type":"journal-article","created":{"date-parts":[[2023,3,15]],"date-time":"2023-03-15T06:32:27Z","timestamp":1678861947000},"page":"100123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Mechanisms of cancer-associated thrombosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Yohei","family":"Hisada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Mackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rpth.2023.100123_bib1","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1182\/blood-2013-04-460121","article-title":"Epidemiology of cancer-associated venous thrombosis","volume":"122","author":"Timp","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/bloodadvances.2021005590","article-title":"The incidence of cancer-associated thrombosis is increasing over time","volume":"6","author":"Mahajan","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100123_bib4","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1002\/cam4.3437","article-title":"Cancer associated thrombosis and mortality in patients with cancer stratified by Khorana score risk levels","volume":"9","author":"Khorana","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.rpth.2023.100123_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/2040620711422590","article-title":"Prevention and treatment of venous thromboembolism in patients with cancer","volume":"3","author":"Hogg","year":"2012","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.rpth.2023.100123_bib6","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100123_bib7","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1182\/blood-2013-04-460147","article-title":"Biomarkers for prediction of venous thromboembolism in cancer","volume":"122","author":"Pabinger","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"issue":"Supplement 1","key":"10.1016\/j.rpth.2023.100123_bib9","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.thromres.2017.12.018","article-title":"Mouse models of cancer-associated thrombosis","volume":"164","author":"Hisada","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1161\/ATVBAHA.117.309846","article-title":"Tissue factor: an essential mediator of hemostasis and trigger of thrombosis","volume":"38","author":"Grover","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2023.100123_bib11","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-06-2351","article-title":"Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer","volume":"13","author":"Khorana","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rpth.2023.100123_bib12","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1200\/JCO.2009.22.6324","article-title":"Role of tissue factor in cancer","volume":"27","author":"Kasthuri","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.rpth.2023.100123_bib13","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1182\/blood-2004-05-2042","article-title":"Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis","volume":"105","author":"Yu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib14","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/JTO.0b013e31817c1b21","article-title":"Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation","volume":"3","author":"Regina","year":"2008","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.rpth.2023.100123_bib15","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1373\/clinchem.2009.123695","article-title":"Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN","volume":"55","author":"Regina","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.rpth.2023.100123_bib16","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.21037\/atm-20-6619","article-title":"Anaplastic lymphoma kinase rearrangement may increase the incidence of venous thromboembolism by increasing tissue factor expression in advanced lung adenocarcinoma","volume":"8","author":"Yang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.rpth.2023.100123_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/jth.15215","article-title":"Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study","volume":"19","author":"Roopkumar","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib18","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jtho.2020.04.033","article-title":"Impact of ALK rearrangement on venous and arterial thrombotic risk in NSCLC","volume":"15","author":"Al-Samkari","year":"2020","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.rpth.2023.100123_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cllc.2016.10.007","article-title":"ALK-rearranged non-small-cell lung cancer is associated with a high rate of venous thromboembolism","volume":"18","author":"Zer","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib20","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/j.cllc.2017.07.001","article-title":"Thromboembolism in anaplastic lymphoma kinase-rearranged non-small cell lung cancer","volume":"19","author":"Alexander","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40248-017-0097-0","article-title":"Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma","volume":"12","author":"Davidsson","year":"2017","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.rpth.2023.100123_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1160\/TH13-11-0956","article-title":"Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer","volume":"111","author":"Lee","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.thromres.2015.09.006","article-title":"Incidence of CT scan-detected pulmonary embolism in patients with oncogene-addicted, advanced lung adenocarcinoma","volume":"136","author":"Verso","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib24","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"Solomon","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100123_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1311107","article-title":"Ceritinib in ALK-rearranged non-small-cell lung cancer","volume":"370","author":"Shaw","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100123_bib26","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"Shaw","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100123_bib27","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/S1470-2045(16)30392-8","article-title":"Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1\/2 trial","volume":"17","author":"Gettinger","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.rpth.2023.100123_bib28","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1182\/blood.2020007488","article-title":"Genomic profiling identifies somatic mutations predicting thromboembolic risk in patients with solid tumors","volume":"137","author":"Dunbar","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rpth.2023.100123_bib30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.rpth.2023.100123_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00401-016-1620-7","article-title":"Mutant IDH1 and thrombosis in gliomas","volume":"132","author":"Unruh","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.rpth.2023.100123_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.rpth.2023.100123_bib33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/jth.12242","article-title":"Coagulation-related gene expression profile in glioblastoma is defined by molecular disease subtype","volume":"11","author":"Magnus","year":"2013","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib34","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s00018-011-0689-3","article-title":"Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles","volume":"68","author":"Gyorgy","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.rpth.2023.100123_bib35","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1538-7836.2007.02369.x","article-title":"Microparticle-associated tissue factor activity: a link between cancer and thrombosis?","volume":"5","author":"Tesselaar","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib36","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1111\/j.1538-7836.2008.03156.x","article-title":"Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer","volume":"6","author":"Khorana","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2011.06.004","article-title":"Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity","volume":"129","author":"Lee","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.thromres.2019.07.011","article-title":"Increasing the sensitivity of the human microvesicle tissue factor activity assay","volume":"182","author":"Vallier","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib39","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.thromres.2020.09.020","article-title":"A\u00a0new hybrid immunocapture bioassay with improved reproducibility to measure tissue factor-dependent procoagulant activity of microvesicles from body fluids","volume":"196","author":"Franco","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib40","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1111\/jth.12718","volume":"12","author":"Tatsumi","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/MBC.0b013e328354a256","article-title":"Microparticle-associated tissue factor activity measured with the Zymuphen MP-TF kit and the calibrated automated thrombogram assay","volume":"23","author":"Hellum","year":"2012","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.rpth.2023.100123_bib42","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/cas.15276","article-title":"Tissue factor and its procoagulant activity on cancer-associated thromboembolism in pancreatic cancer: comment by Mackman et\u00a0al","volume":"113","author":"Mackman","year":"2022","journal-title":"Cancer Sci"},{"key":"10.1016\/j.rpth.2023.100123_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1160\/TH10-03-0187","article-title":"Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma","volume":"105","author":"Auwerda","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/eci.12042","article-title":"Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features","volume":"43","author":"Thaler","year":"2013","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.rpth.2023.100123_bib45","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/bjc.2016.170","article-title":"Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?","volume":"115","author":"Woei-A-Jin","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2018.03.001","article-title":"Comparison of microvesicle tissue factor activity in non-cancer severely ill patients and cancer patients","volume":"165","author":"Hisada","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib47","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/j.1538-7836.2009.03504.x","article-title":"Microparticle-associated tissue factor activity in cancer patients with and without thrombosis","volume":"7","author":"Tesselaar","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib48","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1160\/TH12-02-0099","article-title":"Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study","volume":"108","author":"van Doormaal","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib49","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.thromres.2013.06.026","article-title":"Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers","volume":"132","author":"Bharthuar","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib50","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/rth2.12317","article-title":"Effect of chemotherapy and longitudinal analysis of circulating extracellular vesicle tissue factor activity in patients with pancreatic and colorectal cancer","volume":"4","author":"Kasthuri","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1538-7836.2012.04754.x","article-title":"Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients","volume":"10","author":"Thaler","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib52","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.bjc.6603552","article-title":"Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer","volume":"96","author":"Uno","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/IGC.0000000000000848","article-title":"Expression of tissue factor in epithelial ovarian carcinoma is involved in the development of venous thromboembolism","volume":"27","author":"Sakurai","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib54","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.thromres.2013.09.016","article-title":"Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk","volume":"132","author":"Abu Saadeh","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ygyno.2017.04.021","article-title":"Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer","volume":"146","author":"Cohen","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.rpth.2023.100123_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207387","article-title":"Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin","volume":"13","author":"Gezelius","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2023.100123_bib57","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/ATVBAHA.122.318463","article-title":"Histopathological features of cancer-associated venous thromboembolism: presence of intrathrombus cancer cells and prothrombotic factors","volume":"43","author":"Gi","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2023.100123_bib58","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/ATVBAHA.122.318715","article-title":"Circulating tumor cells and cancer-associated venous thrombosis: a missing link","volume":"43","author":"Mackman","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2023.100123_bib59","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.20082297","article-title":"Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in\u00a0vivo","volume":"206","author":"Thomas","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rpth.2023.100123_bib60","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1182\/blood-2012-01-402156","article-title":"Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/jth.13181","article-title":"Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice","volume":"14","author":"Geddings","year":"2016","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib62","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1111\/jth.13002","article-title":"Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice","volume":"13","author":"Thomas","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib63","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1161\/ATVBAHA.117.310262","article-title":"Distinct pathogenesis of pancreatic cancer microvesicle-associated venous thrombosis identifies new antithrombotic targets in\u00a0vivo","volume":"38","author":"Stark","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.rpth.2023.100123_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2020.100020","article-title":"Role of tissue-factor bearing extracellular vesicles released from ovarian cancer cells in platelet aggregation in\u00a0vitro and venous thrombosis in mice","volume":"2","author":"Sasano","year":"2021","journal-title":"Thromb Update"},{"key":"10.1016\/j.rpth.2023.100123_bib65","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1538-7836.2008.02987.x","article-title":"Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation","volume":"6","author":"Davila","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib66","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/jth.13809","article-title":"Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size","volume":"15","author":"Hisada","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib67","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1182\/blood.2019001388","article-title":"Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin","volume":"134","author":"Suzuki-Inoue","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib68","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2016-06-720714","article-title":"Podoplanin expression in primary brain tumors induces platelet aggregation and increases risk of venous thromboembolism","volume":"129","author":"Riedl","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1440-1827.2005.01791.x","article-title":"Podoplanin as a marker for mesothelioma","volume":"55","author":"Kimura","year":"2005","journal-title":"Pathol Int"},{"key":"10.1016\/j.rpth.2023.100123_bib70","doi-asserted-by":"crossref","first-page":"8552","DOI":"10.1038\/sj.onc.1207869","article-title":"Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors","volume":"23","author":"Kato","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.rpth.2023.100123_bib71","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/jth.14129","article-title":"Combination of isocitrate dehydrogenase 1 (IDH1) mutation and podoplanin expression in brain tumors identifies patients at high or low risk of venous thromboembolism","volume":"16","author":"Mir Seyed Nazari","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib72","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.28732","article-title":"Mutant IDH1 inhibits PI3K\/Akt signaling in human glioma","volume":"120","author":"Birner","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib73","doi-asserted-by":"crossref","first-page":"S136","DOI":"10.1016\/j.thromres.2018.01.021","article-title":"Single cell coagulomes as constituents of the oncogene-driven coagulant phenotype in brain tumours","volume":"164","author":"Tawil","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib74","first-page":"767","article-title":"Purification and characterization of the platelet-aggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26","volume":"55","author":"Toyoshima","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.rpth.2023.100123_bib75","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1093\/neuonc\/nou106","article-title":"Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas","volume":"16","author":"Thaler","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.rpth.2023.100123_bib76","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.thromres.2021.01.008","article-title":"Blocking podoplanin inhibits platelet activation and decreases cancer-associated venous thrombosis","volume":"200","author":"Wang","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib77","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/ijc.29837","article-title":"The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study","volume":"138","author":"Mege","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib78","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/jth.13604","article-title":"C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice","volume":"15","author":"Shirai","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib79","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bj.2019.07.001","article-title":"Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer","volume":"43","author":"Lee","year":"2020","journal-title":"Biomed J"},{"key":"10.1016\/j.rpth.2023.100123_bib80","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1182\/bloodadvances.2020002998","article-title":"Glioblastoma cell populations with distinct oncogenic programs release podoplanin as procoagulant extracellular vesicles","volume":"5","author":"Tawil","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100123_bib81","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jth.15544","article-title":"Podoplanin promotes tumor growth, platelet aggregation, and venous thrombosis in murine models of ovarian cancer","volume":"20","author":"Sasano","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib82","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.rpth.2023.100123_bib83","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2023.100123_bib84","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1055\/s-0038-1648489","article-title":"Effect of leukocyte proteinases on tissue factor pathway inhibitor","volume":"67","author":"Petersen","year":"1992","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib85","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.rpth.2023.100123_bib86","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.rpth.2023.100123_bib87","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1158\/1078-0432.CCR-15-2463","article-title":"Tumor-produced interleukin-8 attracts human myeloid-derived suppressor cells and elicits extrusion of neutrophil extracellular traps (NETs)","volume":"22","author":"Alfaro","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.rpth.2023.100123_bib88","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/path.5753","article-title":"Heterogenous presence of neutrophil extracellular traps in human solid tumours is partially dependent on IL-8","volume":"255","author":"de Andrea","year":"2021","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.rpth.2023.100123_bib89","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3389\/fimmu.2019.02088","article-title":"IL-1beta blockade attenuates thrombosis in a neutrophil extracellular trap-dependent breast cancer model","volume":"10","author":"Gomes","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.rpth.2023.100123_bib90","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20190354","article-title":"Interleukin-17-induced neutrophil extracellular traps mediate resistance to checkpoint blockade in pancreatic cancer","volume":"217","author":"Zhang","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rpth.2023.100123_bib91","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.rpth.2023.100123_bib92","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1038\/s41467-021-23086-z","article-title":"Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer","volume":"12","author":"Shinde-Jadhav","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.rpth.2023.100123_bib93","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00062.2021","article-title":"Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases","volume":"103","author":"Herre","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.rpth.2023.100123_bib94","first-page":"14075","article-title":"Procoagulant role of neutrophil extracellular traps in patients with gastric cancer","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.rpth.2023.100123_bib95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2016.01.009","article-title":"NETosis promotes cancer-associated arterial microthrombosis presenting as ischemic stroke with troponin elevation","volume":"139","author":"Thalin","year":"2016","journal-title":"Thromb Res"},{"issue":"Supplement 3","key":"10.1016\/j.rpth.2023.100123_bib96","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.21037\/cdt.2017.08.01","article-title":"Neutrophil extracellular traps are increased in cancer patients but does not associate with venous thrombosis","volume":"7","author":"Oklu","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"10.1016\/j.rpth.2023.100123_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191231","article-title":"Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer","volume":"13","author":"Thalin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2023.100123_bib98","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1111\/jth.15003","article-title":"Quantification of citrullinated histones: development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma","volume":"18","author":"Thalin","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib99","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1038\/s41598-021-84476-3","article-title":"Prognostic value of circulating markers of neutrophil activation, neutrophil extracellular traps, coagulation and fibrinolysis in patients with terminal cancer","volume":"11","author":"Rosell","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2023.100123_bib100","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2049487","article-title":"Neutrophil extracellular traps promote cancer-associated inflammation and myocardial stress","volume":"11","author":"Cedervall","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.rpth.2023.100123_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250265","article-title":"ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in\u00a0vivo","volume":"16","author":"Hayden","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.rpth.2023.100123_bib102","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jth.13951","article-title":"Citrullinated histone H3, a biomarker of neutrophil extracellular trap formation, predicts the risk of venous thromboembolism in cancer patients","volume":"16","author":"Mauracher","year":"2018","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib103","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618825310","article-title":"Contact system activation and neutrophil extracellular trap markers: risk factors for portal vein thrombosis in patients with hepatocellular carcinoma","volume":"25","author":"Seo","year":"2019","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.rpth.2023.100123_bib104","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1038\/s41375-019-0500-2","article-title":"High circulating levels of MPO-DNA are associated with thrombosis in patients with MPN","volume":"33","author":"Guy","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.rpth.2023.100123_bib105","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bjh.15906","article-title":"Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer","volume":"186","author":"Grilz","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/j.rpth.2023.100123_bib106","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1161\/STROKEAHA.119.026373","article-title":"Circulating DNAs, a marker of neutrophil extracellular traposis and cancer-related stroke: the OASIS-cancer study","volume":"50","author":"Bang","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/j.rpth.2023.100123_bib107","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1158\/0008-5472.CAN-14-3299","article-title":"Neutrophil extracellular traps accumulate in peripheral blood vessels and compromise organ function in tumor-bearing animals","volume":"75","author":"Cedervall","year":"2015","journal-title":"Cancer Res"},{"key":"10.1016\/j.rpth.2023.100123_bib108","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.1038\/s41598-017-06893-7","article-title":"Tumor-derived exosomes induce the formation of neutrophil extracellular traps: implications for the establishment of cancer-associated thrombosis","volume":"7","author":"Leal","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.rpth.2023.100123_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan8292","article-title":"Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms","volume":"10","author":"Wolach","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.rpth.2023.100123_bib110","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3324\/haematol.2019.217083","article-title":"Neutrophils and neutrophil extracellular traps enhance venous thrombosis in mice bearing human pancreatic tumors","volume":"105","author":"Hisada","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.rpth.2023.100123_bib111","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3748\/wjg.v28.i26.3132","article-title":"Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer","volume":"28","author":"Li","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.rpth.2023.100123_bib112","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1182\/blood-2010-02-267740","article-title":"Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1","volume":"116","author":"Meltzer","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.rpth.2023.100123_bib113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0361-090X(02)00002-8","article-title":"The active fraction of plasmatic plasminogen activator inhibitor type 1 as a possible indicator of increased risk for metastatic melanoma","volume":"26","author":"Hanekom","year":"2002","journal-title":"Cancer Detect Prev"},{"key":"10.1016\/j.rpth.2023.100123_bib114","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1135::AID-CNCR6>3.0.CO;2-2","article-title":"The role of cysteine and serine proteases in colorectal carcinoma","volume":"86","author":"Herszenyi","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib115","first-page":"1153","article-title":"Plasma plasminogen activator inhibitor-1 (PAI-1) levels in breast cancer - relationship with clinical outcome","volume":"34","author":"Ferroni","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.rpth.2023.100123_bib116","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/1097-0142(19920615)69:12<2884::AID-CNCR2820691204>3.0.CO;2-S","article-title":"Peaks in plasma plasminogen activator inhibitor-1 concentration may explain thrombotic events in cases of pancreatic carcinoma","volume":"69","author":"Andren-Sandberg","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib117","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.thromres.2014.08.007","article-title":"Active PAI-1 as marker for venous thromboembolism: case-control study using a comprehensive panel of PAI-1 and TAFI assays","volume":"134","author":"Bollen","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.rpth.2023.100123_bib118","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/bloodadvances.2020003149","article-title":"Plasminogen activator inhibitor 1 and venous thrombosis in pancreatic cancer","volume":"5","author":"Hisada","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.rpth.2023.100123_bib119","doi-asserted-by":"crossref","first-page":"16883","DOI":"10.18632\/oncotarget.24721","article-title":"Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma","volume":"9","author":"Kondo","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.rpth.2023.100123_bib120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12967-020-02239-6","article-title":"Plasminogen activator inhibitor-2 (PAI-2) overexpression supports bladder cancer development in PAI-1 knockout mice in N-butyl-N- (4-hydroxybutyl)-nitrosamine- induced bladder cancer mouse model","volume":"18","author":"Furuya","year":"2020","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.rpth.2023.100123_bib121","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-015-0418-x","article-title":"Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma","volume":"14","author":"Chen","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.rpth.2023.100123_bib122","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/jth.12644","article-title":"Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism","volume":"12","author":"Obi","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib123","first-page":"183","article-title":"Thrombo-inflammatory biomarkers in pulmonary embolism as stratified in cancer and non-cancer patient groups","volume":"6","author":"Siddiqui","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.rpth.2023.100123_bib124","first-page":"170","article-title":"Neutrophils and platelets collaborate to induce an increase NET formation during JAK2V617F positive myeloproliferative neoplasm","volume":"6","author":"Guy","year":"2022","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Research and Practice in Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2475037923000924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:27:49Z","timestamp":1762864069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2475037923000924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":124,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2475037923000924"],"URL":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100123","relation":{},"ISSN":["2475-0379"],"issn-type":[{"value":"2475-0379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms of cancer-associated thrombosis","name":"articletitle","label":"Article Title"},{"value":"Research and Practice in Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rpth.2023.100123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}],"article-number":"100123"}}